Evidence map›Paper›PMID 36438828›Full record

ArticleFrontiers in pharmacology2022

Evelien G E Hurkmans, Jan B Koenderink, Jeroen J M W van den Heuvel, Yvonne M H Versleijen-Jonkers, Melissa H S Hillebrandt-Roeffen, Johanne M Groothuismink, Hanneke I Vos, Winette T A van der Graaf, Uta Flucke, Grigor Muradjan and 20 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. [Glutamine metabolic reprogramming in regulating the occurrence and development of osteosarcoma].Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2025
    Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors at 12 institutions in 4 countries.

Evelien G E HurkmansDepartment of Human Genetics, Radboud University Medical Center, Nijmegen, Netherlands.
Jan B KoenderinkDepartment of Pharmacology and Toxicology, Radboud University Medical Center, Nijmegen, Netherlands.
Jeroen J M W van den HeuvelDepartment of Pharmacology and Toxicology, Radboud University Medical Center, Nijmegen, Netherlands.
Yvonne M H Versleijen-JonkersDepartment of Medical Oncology, Radboud University Medical Center, Nijmegen, Netherlands.
Melissa H S Hillebrandt-RoeffenDepartment of Medical Oncology, Radboud University Medical Center, Nijmegen, Netherlands.
Johanne M GroothuisminkDepartment of Human Genetics, Radboud University Medical Center, Nijmegen, Netherlands.
Hanneke I VosDepartment of Human Genetics, Radboud University Medical Center, Nijmegen, Netherlands.
Winette T A van der GraafDepartment of Medical Oncology, Radboud University Medical Center, Nijmegen, Netherlands.
Uta FluckeDepartment of Pathology, Radboud University Medical Center, Nijmegen, Netherlands.
Grigor MuradjanDepartment of Pharmacology and Toxicology, Radboud University Medical Center, Nijmegen, Netherlands.
Hendrik W B SchreuderDepartment of Orthopedics, Radboud University Medical Center, Nijmegen, Netherlands.
Melanie M HagleitnerPrincess Maxima Center for Pediatric Oncology, Utrecht, Netherlands.
Han G BrunnerDepartment of Human Genetics, Radboud University Medical Center, Nijmegen, Netherlands.
Hans GelderblomDepartment of Medical Oncology, Leiden University Medical Center, Leiden, Netherlands.
Anne-Marie Cleton-JansenDepartment of Pathology, Leiden University Medical Center, Leiden, Netherlands.
Henk-Jan GuchelaarDepartment of Clinical Pharmacy & Toxicology, Leiden University Medical Center, Leiden, Netherlands.
Eveline S J M de BontDepartment of Pediatrics, Beatrix Children's Hospital, University Medical Center Groningen, Groningen, Netherlands.
Daan J TouwDepartment of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, Groningen, Netherlands.
G Jan NijhoffDepartment of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, Groningen, Netherlands.
Leontien C M KremerDepartment of Pediatrics, Amsterdam University Medical Centers, Emma Children's Hospital, Amsterdam, Netherlands.
Huib CaronDepartment of Pediatrics, Amsterdam University Medical Centers, Emma Children's Hospital, Amsterdam, Netherlands.
Rachael WindsorPediatric & Adolescent Division, University College London Hospitals NHS Foundation Trust, London, United Kingdom.
Ana Patiño-GarcíaDepartment of Pediatrics, Clínica Universidad de Navarra, Solid Tumor Program, CIMA, Pamplona, Spain.
Anna González-NeiraHuman Genotyping Unit-CeGen, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
Federica SalettaChildren's Cancer Research Unit, The Children's Hospital at Westmead, Sydney, NSW, Australia.
Geoff McCowageCancer Centre for Children, The Children's Hospital at Westmead, Sydney, NSW, Australia.
Sumanth NagabushanCancer Centre for Children, The Children's Hospital at Westmead, Sydney, NSW, Australia.
Daniel CatchpooleChildren's Cancer Research Unit, The Children's Hospital at Westmead, Sydney, NSW, Australia.
D Maroeska W M Te LooDepartment of Pediatrics, Amalia Children's Hospital, Radboud University Medical Center, Nijmegen, Netherlands.
Marieke J H CoenenDepartment of Human Genetics, Radboud University Medical Center, Nijmegen, Netherlands.
Radboud University Nijmegen · NLRadboud University Medical Center · NLChildren's Hospital at Westmead · AULeiden University Medical Center · NLUniversity Medical Center Groningen · NLAmsterdam University Medical Centers · NLClinica Universidad de Navarra · ESEmma Kinderziekenhuis · NLPrincess Máxima Center · NLSpanish National Cancer Research Centre · ESUniversity College London Hospitals NHS Foundation Trust · GBUniversity of Sydney · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

doxorubicinearly disease progressionL-type amino acid transporter 2osteosarcomapharmacogenetics

Identifiers

PMID36438828
PMCPMC9681801
OpenAlexW4308721981

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.